In tumor tissues from a mouse xenograft model established with human MM cell line JJN3, both AKT and mTOR activation was also decreased by C96, which is consistent with studies at the the cellular level, therefore, C96-delayed myeloma tumor growth is consistent with its inhibition on PI3K. The gene discussed is MTOR; the disease is Miyoshi myopathy.